Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Novavax, Inc.
  6. Financials
    NVAX   US6700024010

NOVAVAX, INC.

(NVAX)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-31 pm EST
10.91 USD   +2.44%
05:47pFactbox-What ending the U.S. COVID health emergency means for your pocket
RE
01/26FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/26Novavax needs 6 months to produce annual COVID shots that match new variants
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 93,34 07910 817938938-
Enterprise Value (EV)1 3353 8369 756-517-5082,70
P/E ratio -0,72x-15,3x-6,10x-1,53x-1,84x-2,60x
Yield ------
Capitalization / Revenue 5,00x8,58x9,44x0,48x0,76x0,91x
EV / Revenue 18,0x8,07x8,51x-0,27x-0,41x0,00x
EV / EBITDA ---1,14x1,02x-
Enterprise Value (EV) / FCF -2,42x-39,5x36,8x1,68x0,97x-0,02x
FCF Yield -41,3%-2,53%2,72%59,6%103%-4 317%
Price to Book -0,69x12,6x-30,9x-1,69x-2,18x-1,02x
Nbr of stocks (in thousands) 23 44936 57875 60885 97985 979-
Reference price (USD) 3,9811214310,910,910,9
Announcement Date 03/11/202003/01/202102/28/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 18,74761 1461 9471 2331 036
EBITDA1 ----455-499-
Operating profit (EBIT)1 -130-417-1 687-480-474-307
Operating Margin -694%-87,6%-147%-24,7%-38,5%-29,6%
Pre-Tax Profit (EBT)1 -133-418-1 715-548-479-314
Net income1 -133-418-1 744-535-487-337
Net margin -711%-87,9%-152%-27,5%-39,5%-32,5%
EPS2 -5,51-7,27-23,4-7,12-5,93-4,20
Free Cash Flow1 -138-97,2265-309-525-117
FCF margin -742%-20,4%23,2%-15,8%-42,5%-11,2%
FCF Conversion ---67,9%105%-
Dividend per Share2 ------
Announcement Date 03/11/202003/01/202102/28/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales1 704186735365368365
EBITDA ---119---
Operating profit (EBIT)1 209-483-127-93,3-122-88,9
Operating Margin 29,7%-260%-17,3%-25,6%-33,2%-24,4%
Pre-Tax Profit (EBT)1 206-509-166-91,6-124-91,1
Net income1 203-510-169-80,4-118-86,5
Net margin 28,9%-275%-23,0%-22,1%-32,1%-23,7%
EPS2 2,56-6,53-2,15-1,14-1,71-1,63
Dividend per Share ------
Announcement Date 05/09/202208/08/202211/08/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 242-----
Net Cash position1 -2431 0611 4551 446935
Leverage (Debt / EBITDA) ---3,20x2,89x-
Free Cash Flow1 -138-97,2265-309-525-117
ROE (Net Profit / Equities) --190%-1 266%---
Shareholders' equity1 -221138---
ROA (Net Profit / Asset) -74,4%-47,7%-83,8%-17,3%-26,3%-39,6%
Assets1 1788782 0803 0911 852850
Book Value Per Share2 -5,758,84-4,64-6,44-5,01-10,7
Cash Flow per Share2 ----6,18-8,60-
Capex1 1,8622057,575,566,337,5
Capex / Sales 9,95%46,3%5,01%3,87%5,38%3,62%
Announcement Date 03/11/202003/01/202102/28/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 938 030 366
Net sales (USD) 1 146 290 000
Number of employees 1 541
Sales / Employee (USD) 743 861
Free-Float 98,6%
Free-Float capitalization (USD) 925 118 066
Avg. Exchange 20 sessions (USD) 77 506 587
Average Daily Capital Traded 8,26%
EPS & Dividend